Document is current
Any future updates will be listed below
-
Authors
Kolben, Thomas
Müller, Lena
Meister, Sarah
Keilmann, Lucia
Buschmann, Christina
Trillsch, Fabian
Burges, Alexander
Czogalla, Bastian
Mitter, Sophie
Schmoeckel, Elisa
Corradini, Stefanie
Mahner, Sven
Jeschke, Udo https://orcid.org/0000-0003-2623-3235
Kessler, Mirjana
Beyer, Susanne
-
Funding
Funding for this research was provided by:
Universitätsklinik München
- License Information
-
More Information
Article History
Received: 7 February 2022
Accepted: 27 May 2022
First Online: 21 June 2022
Declarations
:
: T. Kolben has a relative employed at Roche and holds stock of Roche. F. Trillsch declares research support, advisory board, honoraria and travel expenses from AstraZeneca, Clovis, Eisai, Medac, MSD, PharmaMar, Roche, Tesaro/GSK. S. Mahner has received research support, advisory board, honoraria and travel expenses from AstraZeneca, Clovis, Eisai, GlaxoSmithKline, Medac, MSD, Novartis, Olympus, PharmaMar, Roche, Sensor Kinesis, Teva, Tesaro. All the other authors declare that they have no conflict of interest.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Ludwig-Maximilians University Munich (reference number: 19-249, 2019).
: Patient data were anonymized. Consent to participate is not applicable as all data are anonymized.
: Not applicable as all data are anonymized.
